Pharma: Trends in e-detailing
18.2K views | +4 today
Follow
 
Rescooped by eMedToday from Digital marketing pharma
onto Pharma: Trends in e-detailing
Scoop.it!

iPad vs. Windows 8 Surface: Which is Better for Pharma?

iPad vs. Windows 8 Surface: Which is Better for Pharma? | Pharma: Trends in e-detailing | Scoop.it

The iPad vs. the Surface Pro. iOS vs. Windows 8. Apple vs. Microsoft. Have these two tech heavyweights elicited an internal debate within pharma companies over which device is better for their sales teams or is the choice a foregone conclusion? After all, pharma has already heavily adopted the iPad and they are not alone. According to preliminary data from the International Data Corporation (IDC) Worldwide Quarterly Tablet Tracker, worldwide tablet shipments have increased 142.4% year over year in the first quarter of 2013 with Apple capturing 39.6% of the market share of tablet operating systems compared to Microsoft’s 3.3%—however Android comes out on top with 56.5%. Of course, Microsoft has only recently ramped up its presence in this market with its release of the Surface RT and Surface Pro in the beginning of this year and we wouldn’t be having this discussion if pharma didn’t have some reservations over the iPad.


Via Olivier Delannoy
eMedToday's insight:

The answer:

 

“Right now the iPad has no competition within the healthcare market,” says Richard Meyer, Director at Online Strategic Solutions. “While the Windows 8 Surface does have some advantages, such as the ability to integrate with people using the Windows operating system, the very slow adoption of Windows 8 and the problems with the interface are going to continue to ensure that Apple is the first choice for healthcare professionals.”

more...
No comment yet.
Pharma: Trends in e-detailing
Learn what is happening in e-detailing
Curated by eMedToday
Your new post is loading...
Your new post is loading...
Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

Why multichannel is not an in/out option

Why multichannel is not an in/out option | Pharma: Trends in e-detailing | Scoop.it
Multichannel, long a hot topic for pharma, continues to stimulate more debate than an EU referendum. But as models of communication evolve in time with digital revolution, multichannel is not an in/out choice - it's the real world. Pharma is slowly making progress, but excellence? It's not a familiar experience.
Via Philippe Marchal, Lionel Reichardt / le Pharmageek, eMedToday
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

7 Habits of Highly Effective Pharma Sales Reps (Pharma Sales and Marketing Trends)

7 Habits of Highly Effective Pharma Sales Reps (Pharma Sales and Marketing Trends) | Pharma: Trends in e-detailing | Scoop.it
We’ve searched the web and curated these 7 habits of highly effective pharma sales reps, to help you to meet the challenges of the new healthcare environment.
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

iPad and Tablet Use in Detailing: Where Pharma is Going Wrong | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma

iPad and Tablet Use in Detailing: Where Pharma is Going Wrong | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma | Pharma: Trends in e-detailing | Scoop.it
The hardware is an important factor, but is your sales force utilizing these to gain a strategic advantage or are they using it more as a glorified PDF viewer?
more...
No comment yet.
Rescooped by eMedToday from #eHealthPromotion, #web2salute
Scoop.it!

The Average App Loses More Than 75% Of Its Users After One Day - The bad news … the majority of apps have a day to prove their worth.

The Average App Loses More Than 75% Of Its Users After One Day - The bad news … the majority of apps have a day to prove their worth. | Pharma: Trends in e-detailing | Scoop.it
A week is a long time in politics. In terms of app retention rates, seven days is a lifetime.

 

Most apps have a shelf life of less than a week. An app now has to hit the ground running, build an audience and—hopefully—be useful enough to warrant repeat use.

For developers who have devoted blood and sweat to a project, seven days is a poor return on their investment. The good news is that the number of installs is still going to grow in the next four years, according to IDC. The bad news … the majority of apps have a day to prove their worth.

A report by mobile marketing company Appboy said that less than 25% of people return to an app the day after initial install.

Appboy’s Spring 2016 Mobile Customer Retention Report analyzed data from 300 apps coupled with 300 million user profiles to break down day-to-day retention rates, with the intention being to provide developers or brands with an insight into how likely it would be that people would return. Apps on Appboy’s platform with a monthly active user figure of 5,000 through November 2015 to March 2016 were studied.


Via Giuseppe Fattori
more...
No comment yet.
Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

12 Big Pharma Stats That Will Blow You Away -- The Motley Fool

12 Big Pharma Stats That Will Blow You Away --  The Motley Fool | Pharma: Trends in e-detailing | Scoop.it
Big Pharma means big numbers -- usually. But there are some small numbers that are fascinating, too.

Via Richard Meyer, eMedToday
more...
No comment yet.
Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

Five Ways Pharma Can Benefit From Digital Health Technologies

Five Ways Pharma Can Benefit From Digital Health Technologies | Pharma: Trends in e-detailing | Scoop.it
Healthcare has been understandably late to the widespread adoption of digital technology. Extremely restrictive regulations, the presence of multiple key stakeholders, a slow-to-adopt culture and other challenges distinguish healthcare from the retail and finance sectors, which have flourished with their implementations of digital technologies. But pharmaceutical companies (pharma) inhabit a unique position, situated between patients, prescribers and payers, allowing them to gain maximum benefits from a wide array of digital offerings.
Via Alex Butler, Rémy TESTON, Philippe Marchal, Lionel Reichardt / le Pharmageek, eMedToday
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

Mobile app allows GlaxoSmithKline to track patients in real-time arthritis study

Mobile app allows GlaxoSmithKline to track patients in real-time arthritis study | Pharma: Trends in e-detailing | Scoop.it
GlaxoSmithKline has become the first pharmaceuticals company to use a medical research app from Apple to study how disease affects patients in real time.
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

Mobile Technology Increases Patient Engagement - PharmaVOICE

Mobile Technology Increases Patient Engagement - PharmaVOICE | Pharma: Trends in e-detailing | Scoop.it
The industry needs to act on the opportunity to be in the pockets of its consumers.
more...
No comment yet.
Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

Budget Allocations For Medical Marketing [CHART] - e-Strategy Trends

Budget Allocations For Medical Marketing [CHART] - e-Strategy Trends | Pharma: Trends in e-detailing | Scoop.it
Professionals meetings and conferences occupy the largest share (13.7%) of medical marketing budgets.
more...
No comment yet.
Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

Digital health: A way for pharma companies to be more relevant in healthcare

Pharmaceutical companies have an opportunity to use their expertise to play a greater role in healthcare reform, while also revamping their business model.
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

How Big IT and Big Pharma are Partnering for Wearables Success

How Big IT and Big Pharma are Partnering for Wearables Success | Pharma: Trends in e-detailing | Scoop.it
How Big IT and Big Pharma are Partnering for Wearables Success
See it on Scoop.it, via Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
more...
No comment yet.
Rescooped by eMedToday from #eHealthPromotion, #web2salute
Scoop.it!

Snapchat: A Social Media Platform Too Far for Pharma Marketing?

Snapchat: A Social Media Platform Too Far for Pharma Marketing? | Pharma: Trends in e-detailing | Scoop.it

Snapchat is a mobile messaging app, initially used to share photos (snaps) that ‘self-destructed’ seconds after they had been viewed. Now, increasingly focused on video and featuring text overlays, photo and geo filters and more emojis that you can imagine, messages sent directly still disappear on viewing, but users now have the option to curate ‘Stories’ where messages last for 24 hours.

 

The network is the fastest growing in social media’s short history, achieving more than 100 million daily users in just four years. And, despite Facebook and Google reportedly trying to buy it for between $3 and $4 billion, Snapchat it is still independent and now valued at $20 billion.

 

Demographics for the platform’s user base skew pretty young – 60 percent of US Snapchat users are under 25; 86 percent are under 35. And the fact that ‘old’ people like me never got Snapchat actually factors in its stellar success. In a survey run earlier this year for Variety magazine, 30 percent of respondents said one of the things they liked most about the social media network was that ‘My parents don’t use it’.

 

Combine the persistence of its messaging functionality, with incredible growth, an exclusive mobile focus, the increasing volume of video on the platform and engagement levels ‘to die for’, and Snapchat could become a very interesting place to be for Pharma marketers targeting younger patients.

 

Writing last year in Ad Age about opportunities for brands joining the platform, Victor Pineiro of the Big Spaceship agency highlighted Snapchat’s ability to deliver what he called ‘intimacy at scale, “Every time a user opens a snap, she has no idea who else – if anyone – is seeing it. It's a tiny, personal gift, even when broadcast to a huge audience.”

 

That intimacy is important to many patient communities. Michael Smith, Senior Digital Strategist at Palio+Ignite, has written, ‘there are certain communities within healthcare marketing that do not lend themselves well to public social media campaigns’. For these groups, he sees apps like Snapchat allowing marketers to develop a ‘social, but private relationship with their target audience without having to drive them to a branded platform’.

 

Of course any advice for Pharma to consider using a social media platform has to come with the usual advisories and warnings.

 

The 24-hour shelf life of Snapchat messages might heighten engagement as users log on to avoid FOMO (fear of missing out), but Pharmaguy suggests it might not be a ready answer for FOFDAR (fear of FDA regulations) even if it would be difficult for the FDA to document transgressions before offeding materials have disappeared.

 

The transience of Snapchat messaging probably doesn’t make it the best place for straight up drug promotions, but it may be effective in promoting educational events or directing people to more permanent sources of information like websites, or for ongoing patient support and adherence.

 

I find it fairly easy to imagine a teen diabetic subscribed to an information channel on their smartphone that sends daily treatment reminders and regularly share messages of support from within the patient community, healthcare professionals and even celebrity ambassadors… especially if they use that rainbow vomit filter.


Via Pharma Guy, Giuseppe Fattori
more...
Pharma Guy's curator insight, May 31, 1:47 PM

Snapchat taps into Pharma's FOFDAR (fear of FDA regulations). If the content disappears in 24 hours, the chances of the FDA seeing it and documenting violations is minimized. Of course, pharma companies must submit promotional material to FDA at the time of distribution, but by then the promotion is gone. I guess the FDA can use that submission as evidence to send enforcement letters. Still, it's only a slap on the wrist as was the case for Kim Kardashian's Instagram post."; http://sco.lt/6qD0yX

 

Meanwhile, Listen to this 3-minute audio snippet, Peter Houston, founder of Flipping Pages Media Ltd, discusses the pros and cons of Tumblr and whether it is possible for pharma marketers to get involved with Tumblr. Is it too Early? http://bit.ly/earlyTumblr 

Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
Scoop.it!

Dragging Pharma Into the Digital Age

Dragging Pharma Into the Digital Age | Pharma: Trends in e-detailing | Scoop.it
The technology in machines such as gene sequencers and bioreactors keeps advancing, but devices rarely talk to each other.

Via Lionel Reichardt / le Pharmageek
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

Digital's Place in the Pharma Marketing Mix

Digital's Place in the Pharma Marketing Mix | Pharma: Trends in e-detailing | Scoop.it
The rush to digital will continue at a fast clip, but marketers need to reacquaint themselves with their brands' audiences.
more...
No comment yet.
Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

Five Ways Pharma Can Benefit From Digital Health Technologies | Digital Health Marketing

Five Ways Pharma Can Benefit From Digital Health Technologies | Digital Health Marketing | Pharma: Trends in e-detailing | Scoop.it
Healthcare has been understandably late to the widespread adoption of digital technology.
more...
No comment yet.
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
Scoop.it!

GSK looking to build gamification into pharmacy digital experience

GSK looking to build gamification into pharmacy digital experience | Pharma: Trends in e-detailing | Scoop.it
The coming together of healthcare giants Glaxo Smith Kline and Novartis to create a consumer health care division will see the company trying new digital i
Via Philippe Marchal, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by eMedToday from Pharma Hub
Scoop.it!

Microneedle Patch for Painless Monitoring of Drug Intake

Microneedle Patch for Painless Monitoring of Drug Intake | Pharma: Trends in e-detailing | Scoop.it
A collaboration between researchers at the University of British Columbia and Paul Scherrer Institut in Switzerland has developed a microneedle device for drug monitoring. The device is in a form of a patch that’s stuck onto the skin, painlessly pushing microneedles through to sample the interstitial fluid.
Via Philippe Marchal
more...
No comment yet.
Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

The Best in B2C Pharmaceutical and Health Care Content Marketing 

Pharmaceutical and healthcare companies have a huge opportunity to be the go-to-source of information people around the world are searching for.
more...
No comment yet.
Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

GlaxoSmithKline targets arthritis in first ResearchKit study by a drug company

GlaxoSmithKline targets arthritis in first ResearchKit study by a drug company | Pharma: Trends in e-detailing | Scoop.it
Apple's ResearchKit was quickly adopted by clinical studies at a series of universities and hospitals, but a new iOS app focused on rheumatoid arthritis from pharmaceutical firm GlaxoSmithKline marks the first time a drug company has made use of the framework.
Via Philippe Marchal, eMedToday
more...
No comment yet.
Rescooped by eMedToday from Pharma Hub
Scoop.it!

Novartis Dives Into the "Virtual Medical Meeting" - Will Medical Societies Push Back?

Novartis Dives Into the "Virtual Medical Meeting" - Will Medical Societies Push Back? | Pharma: Trends in e-detailing | Scoop.it

Novartis is changing the way it engages with healthcare professionals (HCPs) for medical education activities by ramping up its use of digital technology.

Key to these plans will be the company's Vivinda TV virtual conference platform, which went live earlier this year to provide on-demand content from medical meetings.

Intended for HCPs around the world, with the exception of the US, Canada, Japan, Norway and Sweden, Vivinda was used at last month's American Society of Clinical Oncology (ASCO) meeting.

Content from the flagship cancer congress attracted more than 4,600 'virtual delegates' across 103 countries. “That's five times more than were engaged the previous year using traditional sponsorship methods,” Novartis noted.

Pharma companies such as GlaxoSmithKline and Pfizer have been using webinars to reach healthcare professionals for some time, but Novartis' plans appear be a more concerted drive towards virtual meetings.
The changes come as new European pharma industry rules came into effect last week on HCP payment transparency, requiring firms to disclose their payments to HCPs for activities such as travel to congresses.

 The company said: “Conference attendance is by nature restricted to only a small proportion of doctors worldwide, and Novartis is keen to find better and more inclusive ways of reaching a broader cross-section of the medical community. 

Consequently the company has increased its investment in digital technology to record levels and plans to use virtual meetings and web-based customer interaction platforms to engage more with HCPs.

However, Novartis will still offer doctors support to attend medical conferences, but from January 2017 it said this would be based on “active participation in the event”. The firm will also sponsor speakers to represent the company in clearly-defined instances, such as when a new product becomes available.


Via Pharma Guy, Philippe Marchal
more...
Pharma Guy's curator insight, July 5, 7:34 AM

Not that for ASCO, the virtual meeting was not available in the same market that the medical society draws upon for physical attendance. It remains to be seen if Len Starnes is right: that virtual attendees of medical conferences will soon outnumber physical attendees. For more on that, read “The Emerging Virtual Medical Conference: Opportunities for Pharma, HCPs and Patients”; http://bit.ly/pmn130502p 

Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
Scoop.it!

What does the sales rep of the future look like?

What does the sales rep of the future look like? | Pharma: Trends in e-detailing | Scoop.it
The next-gen sales rep won't be a robot. It'll be a human who understands data and knows how to do one important thing better than anything else.

Via Julie O'Donnell, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

Sun Pharma takes mobile app route to raise disease awareness: Abhay Gandhi

Sun Pharma takes mobile app route to raise disease awareness: Abhay Gandhi | Pharma: Trends in e-detailing | Scoop.it
Read more about Sun Pharma takes mobile app route to raise disease awareness: Abhay Gandhi on Business Standard.
more...
No comment yet.
Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

Digital health: A way for pharma companies to be more relevant in healthcare

Pharmaceutical companies have an opportunity to use their expertise to play a greater role in healthcare reform, while also revamping their business model.
more...
No comment yet.
Rescooped by eMedToday from Pharma Hub
Scoop.it!

New FDA draft guidance encourages medical device makers to share data with patients

New FDA draft guidance encourages medical device makers to share data with patients | Pharma: Trends in e-detailing | Scoop.it
In 2012 The Wall Street Journal published a story that quoted a big medical device company spokesperson explaining that they couldn't provide patients the medical device data gathered by implanted devices inside their own bodies because regulators would'nt allow it
Via Philippe Marchal
more...
No comment yet.